Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study

K Fizazi, G Kramer, JC Eymard, CN Sternberg, J De Bono, D Castellano, B Tombal, C Whulfing, M Liontos, J Carles, R Iacovelli, B Melichar, A Sverrisdottir, C Theodore, S Feyerabend, C Helissey, S Oudard, G Facchini, EM Poole, A OzatilganC Geffriaud-Ricouard, S Bensfia, Ronald de Wit

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Scopus)
Original languageEnglish
Pages (from-to)1513-1525
Number of pages13
JournalLancet Oncology
Volume21
Issue number11
DOIs
Publication statusPublished - 2020

Cite this